TotalMarketCap

Apollomics

APLMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$49.465 M

$17.08 -11.09%

Close of 6 Nov 2026

As of 6 Nov 2026, Apollomics (APLM) has a market capitalization of $49.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

2,196,052

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Apollomics lists more than one class of stock. Company figures above cover all classes combined.

APLMW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #334TalpheraTLPH$52.7M
  2. #335Pliant TherapeuticsPLRX$50.5M
  3. #336ApollomicsAPLM$49.5M
  4. #337IntercureINCR$49.4M
  5. #338Werewolf TherapeuticsHOWL$49.3M

What if Apollomics were worth as much as…

Open the what-if tool →

Gold $28.2T

$9,750,123

Per share 570,850× higher

Bitcoin $1.53T

$527,562.20

Per share 30,888× higher

Apple $5.02T

$1,731,937

Per share 101,401× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Apollomics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.